Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › TX › TYLER › TRINCARE INC

TRINCARE INC

NPI: 1033351226 · TYLER, TX 75701 · Clinical Medical Laboratory · NPI assigned 04/02/2009

$1.47M
Total Medicaid Paid
166,332
Total Claims
157,689
Beneficiaries
110
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialHARRISON, MARY (PROVIDER ENROLLMENT COORDINATOR)
NPI Enumeration Date04/02/2009

Related Entities

Other providers sharing the same authorized official: HARRISON, MARY

ProviderCityStateTotal Paid
LINCOLN-WAY HIGH SCHOOL DISTRICT 210 NEW LENOX IL $124K
TRINITY CLINIC HENDERSON TX $437.22
TRINITY CLINIC TYLER TX $0.00

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 5,218 $30K
2019 4,848 $28K
2020 11,057 $144K
2021 18,462 $163K
2022 20,909 $149K
2023 50,640 $460K
2024 55,198 $497K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 8,149 7,881 $204K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 8,115 7,850 $203K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 1,424 1,401 $110K
80061 Lipid panel 10,963 10,517 $77K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 19,716 18,483 $73K
86703 6,546 6,349 $63K
84443 Thyroid stimulating hormone (TSH) 8,172 7,797 $63K
80050 General health panel 2,089 2,012 $62K
80053 Comprehensive metabolic panel 13,841 13,058 $58K
83036 Hemoglobin; glycosylated (A1C) 10,109 9,705 $52K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 1,345 1,306 $49K
80055 1,629 1,562 $47K
88142 2,348 2,288 $33K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types 1,281 1,256 $30K
87086 Culture, bacterial; quantitative colony count, urine 6,135 5,671 $29K
86803 3,704 3,569 $29K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 2,303 2,185 $24K
84439 3,649 3,508 $19K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 845 823 $18K
83655 1,838 1,815 $17K
87070 2,769 2,576 $17K
82105 1,428 1,384 $16K
86592 5,269 5,008 $16K
82728 1,573 1,531 $11K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 613 609 $10K
87808 1,645 1,598 $10K
87340 1,730 1,671 $8K
82950 2,286 2,062 $7K
87081 1,621 1,547 $7K
83970 755 692 $6K
80305 801 749 $6K
86738 542 537 $6K
87186 1,363 1,125 $6K
80076 1,111 1,046 $5K
83540 1,546 1,485 $5K
82570 2,806 2,645 $4K
86762 531 496 $4K
83550 976 942 $4K
82951 460 426 $4K
88305 Level IV - Surgical pathology, gross and microscopic examination 87 58 $3K
80048 Basic metabolic panel (calcium, ionized) 1,596 1,526 $3K
82607 527 497 $3K
86140 1,366 1,310 $3K
82247 916 710 $3K
80069 1,319 1,190 $2K
84702 227 156 $2K
81001 2,872 2,624 $2K
88141 177 172 $2K
86850 570 517 $2K
86780 287 278 $2K
84156 2,030 1,881 $2K
82043 1,342 1,293 $2K
80074 134 134 $2K
82248 654 553 $2K
83021 161 151 $2K
85652 1,231 1,180 $1K
83013 29 29 $1K
85018 623 614 $1K
87205 383 358 $1K
87210 266 255 $1K
87077 253 231 $995.68
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 59 58 $950.70
83735 411 360 $882.67
84450 261 238 $867.80
80081 14 13 $817.44
84460 235 212 $763.87
86901 501 462 $684.63
83880 122 117 $606.26
86900 456 416 $550.54
86885 84 84 $497.77
84403 31 29 $427.86
84481 38 37 $404.70
83525 55 46 $391.42
86038 63 63 $382.85
87088 68 64 $341.03
87209 27 25 $317.10
82952 122 121 $313.94
83001 28 25 $267.18
87045 40 38 $248.19
84466 30 28 $230.22
84146 30 29 $226.19
82310 478 445 $211.36
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 20 15 $206.36
85014 103 102 $190.08
82565 61 55 $189.49
84075 58 55 $187.01
82040 64 60 $180.99
82746 25 25 $172.47
83721 58 55 $171.70
84100 86 77 $163.89
80051 28 27 $148.59
84155 64 60 $133.51
80349 46 44 $124.58
84520 43 41 $117.67
82947 45 37 $102.70
81050 45 41 $99.51
81025 16 16 $93.99
83690 13 13 $65.41
83615 28 24 $58.62
85610 35 27 $48.16
86431 13 13 $47.60
85045 13 12 $40.20
82465 16 15 $24.33
81003 16 14 $18.72
84478 14 13 $14.48
36415 Collection of venous blood by venipuncture 775 721 $10.31
83718 14 13 $2.52
80197 315 233 $0.00
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 73 73 $0.00
84165 16 16 $0.00